Angela Schulz
Associated PI of Research Project 7:
“Adaptive lysosomal signaling mechanisms in CLN3-defective cells”
CONTACT
Dr. med. Angela Schulz
University Medical Center Hamburg-Eppendorf
Children’s Hospital
Martinistr. 52
D-20246 Hamburg
Germany
phone: +49 40 7410 56391
fax: +49 40 7410 55137
an.schulz@uke.de
website Braulke/Schulz Group
KEY PUBLICATIONS
Volumetric description of brain atrophy in neuronal ceroid lipofusincosis 2: Supratentorial gray matter shows uniform disease progression. Löbel U, Sedlacik J, Nickel M, Lezius S, Fiehler J, Nestrasil I, Kohlschütter A, Schulz A (2016) Am J Neuroradiol 37:1938-43
Novel morphological macular findings in juvenile CLN3 disease. Dulz S, Wagenfeld L, Nickel M, Richard G, Schwartz R, Bartsch U, Kohlschütter A, Schulz A (2016) Brit J Ophthalmol 100:824-8
LYSOPLEX: an efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway. Di Fruscio G*, Schulz A*, De Cegli R, Savarese M, Mutarelli M, Parenti G, Banfi S, Braulke T, Nigro V, Ballabio A (2015) Autophagy 11:928-38 (*equal contribution)
Ethical issues with artificial nutrition of children with degenerative brain diseases. Kohlschütter A, Riga C, Crespo D, Torres JM, Penchaszadeh V, Schulz A (2015) Biochim Biophys Acta 1852:1253-6
NCL diseases – Clinical Perspectives. Schulz A, Kohlschütter A, Mink J, Simonati A, Williams R (2013) Biochim Biophys Acta 1832:1801-6
Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene. Kousi M, Anttila V, Schulz A, Calafato S, Jakkula E, Riesch E, Myllykangas L, Kalimo H, Topcu M, Göbken S, Alehan F, Lemke JR, Alber M, Palotie A, Kopra O, Lehesjoki AE (2012) J Med Genet 49:391e399
Identification of potential biomarkers and modifiers of CLN3-disease progression. Lebrun AH, Moll-Khosrawi P, Pohl S, Makrypidi G, Storch S, Kilian D, Streichert T, Otto B, Mole SE, Ullrich K, Cotman S, Kohlschütter A, Braulke T, Schulz A (2011) Mol Med 17:1253-61
Retention of Lysosomal Protein CLN5 in the Endoplasmic Reticulum Causes Neuronal Ceroid Lipofuscinosis in Asian Sibship. Lebrun AH, Storch S, Rüschendorf F, Schmiedt ML, Kyttällä A, Mole SE, Kitzmüller C, Saar K, Mewasingh LD, Boda V, Kohlschütter A, Ullrich K, Braulke T, Schulz A (2009) Hum Mutat 30:E651-61
The CLN9 Protein – A Regulator of Dihydroceramide Synthase. Schulz A, Mousallem T, Venkataramani M, Persaud-Sawin DA, Zucker A, Luberto C, Bielawska A, Bielawski J, Holthuis JCM, Jazwinski SM and Boustany RM (2006) J Biol Chem 281:2784-94
Impaired Cell Adhesion and Apoptosis in the Novel CLN9 Batten Disease Variant. Schulz A, Dhar S, Rylova S, Ucci A, Alroy J, Hagel C, Artacho I, Lin S, Kohlschütter A and Boustany RM (2004) Ann Neurol 56:341-50